secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001493152-24-023871
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos closes $7.5M private placement with Seneca; launches strategic alliance for sleep apnea treatment
--------------------------------------------------------------------------------

- Gross proceeds of $7.5M from sale of 3,220,266 shares/pre-funded warrants and 5-year warrants at $2.329/share to Seneca affiliate V-CO.
- Strategic alliance with Rebis Health (Colorado) to jointly offer CPAP and Vivos' oral appliances at two centers starting July 2024; revenue-sharing model.
- Seneca receives board observation rights and a management services fee of $37,500/quarter; cash participation in alliance net cash flow.
- Company intends to use proceeds for working capital; must file resale registration by July 25, 2024.
- Management expects new model to reduce cash burn, improve gross profit per case, and drive revenue growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224023871/0001493152-24-023871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224023871/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer